Product/Composition:- | Remdesivir |
---|---|
Strength:- | Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL) |
Form:- | Lyophilized powder for IV & Injection |
Reference Brands:- | Veklury® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Remdesivir (Veklury) is an FDA and EMA-approved antiviral used in hospitalized COVID-19 patients. Available as a 100 mg powder or injection solution, it's manufactured by Gilead Sciences. PharmaB2B platforms connect buyers with certified Remdesivir suppliers and distributors in the US and EU, offering compliant sourcing, global shipping, and competitive pricing for hospitals and government tenders.
Remdesivir (Veklury) is a broad-spectrum antiviral approved in the EU and US for the treatment of hospitalized COVID-19 patients. Manufactured by Gilead Sciences, Remdesivir is available as a 100 mg lyophilized powder and 100 mg/20 mL injection solution. As a key product in critical care, it is in demand across hospitals, distributors, and government tenders. Pharmab2B platforms connect verified Remdesivir suppliers, manufacturers, and wholesalers for compliant sourcing. Ensure regulatory-approved procurement in Europe and the United States through trusted B2B pharmaceutical networks offering competitive pricing, supply reliability, and global shipping.